Learn about our proactive and positive approach to this legislationREAD
Independent corporate broking, advisory and trading house focusing on mid & small-cap companies.
Research relationships with over 780 institutions post MiFID II.
Extel Rankings 2017
UK Mid & Small Cap
with UK Fund Managers
with Continental European Fund Managers
with Wealth Managers
13 March 2018
USS100m Accelerated Book Build Placing – PureTech Health
Peel Hunt acted as joint bookrunner on an accelerated book build placing of 45,000,000 new Ordinary shares in PureTech Health plc (representing 19% of the Company) at a price of 160 pence per Placing Share raising gross proceeds of $100 million, as announced on 13th March, 2018.
9 March 2018
Accelerated Book Build Placing – Oxford BioMedica
Peel Hunt acted as joint bookrunner on an accelerated book build placing of 174,346,817 new Ordinary shares in Oxford BioMedica plc (representing 5.3% of the Company) at a price of 11.75 pence per Ordinary Share raising gross proceeds of £20.5 million, as announced on 9th March, 2018.
27 February 2018
IPO (c.£178m fund raise) – IntegraFin Holdings
Peel Hunt acted as sole Sponsor, sole bookrunner and sole Corporate Broker to IntegraFin Holdings plc on its IPO (admission expected 2nd March, 2018) having raised gross proceeds of c.£178m (all secondary shares) as announced on 27th February, 2018.
As a business, we specialise in corporate broking, advisory, research, sales and trading. As a partnership, it is the way we run our business that sets us apart.
Our partnership structure best aligns our interests with those of our clients and stakeholders. We only engage with clients as a house – corporate, sales and research must all agree. This leads to long-term successful client relationships. We call this approach joined-up broking.